Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials.

MLA

Brockmeyer, Maximilian, et al. “Uninterrupted Anticoagulation during Catheter Ablation for Atrial Fibrillation: No Difference in Major Bleeding and Stroke between Direct Oral Anticoagulants and Vitamin K Antagonists in an Updated Meta-Analysis of Randomised Controlled Trials.” Acta Cardiologica, vol. 76, no. 3, May 2021, pp. 288–95. EBSCOhost, https://doi.org/10.1080/00015385.2020.1724689.

APA

Brockmeyer, M., Yingfeng Lin, Parco, C., Karathanos, A., Krieger, T., Schulze, V., Heinen, Y., Bejinariu, A., Müller, P., Hisaki Makimoto, Kelm, M., & Wolff, G. (2021). Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials. Acta Cardiologica, 76(3), 288–295. https://doi.org/10.1080/00015385.2020.1724689

Chicago

Brockmeyer, Maximilian, Yingfeng Lin, Claudio Parco, Athanasios Karathanos, Torben Krieger, Volker Schulze, Yvonne Heinen, et al. 2021. “Uninterrupted Anticoagulation during Catheter Ablation for Atrial Fibrillation: No Difference in Major Bleeding and Stroke between Direct Oral Anticoagulants and Vitamin K Antagonists in an Updated Meta-Analysis of Randomised Controlled Trials.” Acta Cardiologica 76 (3): 288–95. doi:10.1080/00015385.2020.1724689.